{"id":48817,"date":"2025-11-24T00:17:05","date_gmt":"2025-11-23T16:17:05","guid":{"rendered":"https:\/\/flcube.com\/?p=48817"},"modified":"2025-11-24T00:17:06","modified_gmt":"2025-11-23T16:17:06","slug":"johnson-johnson-china-pins-head-alex-he-to-depart-driving-leadership-transition-amid-key-nrdl-product-success","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=48817","title":{"rendered":"Johnson & Johnson China PINS Head Alex He to Depart, Driving Leadership Transition Amid Key NRDL Product Success"},"content":{"rendered":"\n

Johnson & Johnson (J&J, NYSE: JNJ<\/a>) China<\/strong> confirmed a significant leadership change today, announcing that Alex Xuzheng He<\/strong>, Vice President, Head of the PINS<\/strong> (Psychiatry, Infectious Diseases, Neurology, and Pulmonary Arterial Hypertension) Business Unit, and Head of Mature Products, will officially step down from his role on December 31, 2025<\/strong>. This departure marks the end of his nine-year tenure with the company.<\/p>\n\n\n\n

Leadership Transition & Timeline<\/h2>\n\n\n\n
Item<\/th>Detail<\/th><\/tr><\/thead>
Executive<\/strong><\/td>Alex Xuzheng He<\/td><\/tr>
Current Role<\/strong><\/td>VP, Head of PINS BU, Head of Mature Products (China)<\/td><\/tr>
Departure Date<\/strong><\/td>December 31, 2025<\/td><\/tr>
Successor Announcement<\/strong><\/td>Expected early Q1 2026<\/td><\/tr>
Interim Status<\/strong><\/td>Internal interim arrangements pending formal announcement<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Executive Profile and Key Achievements<\/h2>\n\n\n\n

Mr. He brings nearly 28 years<\/strong> of extensive management expertise across pharmaceuticals, therapeutics, and various industries in the Greater China and Asia-Pacific markets.<\/p>\n\n\n\n

During his nine years at Johnson & Johnson<\/strong> (Janssen), his key responsibilities and achievements included:<\/p>\n\n\n\n